HOPMAN MARK (Chief Commercial Officer) sold 0.2% of their position (275.00 shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $3.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2026ACC: 0002048497-26-000008
Officer· Chief Commercial Officer
Since Mar 2026
-275.00
Net shares
Net seller
$3.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
275.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−275.00
Price / share
$12.31
Trade value
$3.39K
% of position
0.2%
6/4/2026
130.89K→130.61K
Total
Net shares
−275.00
Net value
-$3.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2026 | S · Sale | −275.00 | $12.31 | $3.39K | 0.2% | 130.89K | 130.61K |
| Total | −275.00 | -$3.39K | ||||||
Derivative Transactions0
No derivative transactions reported